Currently, there are 769.67M common shares owned by the public and among those 766.35M shares have been available to trade.
The company’s stock has a 5-day price change of 6.55% and 51.61% over the past three months. XPEV shares are trading -13.02% year to date (YTD), with the 12-month market performance down to -23.60% lower. It has a 12-month low price of $6.55 and touched a high of $17.17 over the same period. XPEV has an average intraday trading volume of 15.29 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -0.71%, 4.95%, and 38.45% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of XPeng Inc ADR (NYSE: XPEV) shares accounts for 14.33% of the company’s 769.67M shares outstanding.
It has a market capitalization of $9.81B and a beta (3y monthly) value of 2.75. The earnings-per-share (ttm) stands at -$0.86. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.39% over the week and 5.17% over the month.
Earnings per share for the fiscal year are expected to increase by 65.60%, and 55.93% over the next financial year. EPS should grow at an annualized rate of -5.74% over the next five years, compared to -33.39% over the past 5-year period.
Looking at the support for the XPEV, a number of firms have released research notes about the stock. China Renaissance stated their Buy rating for the stock in a research note on November 22, 2024, with the firm’s price target at $16.70. Goldman coverage for the XPeng Inc ADR (XPEV) stock in a research note released on November 21, 2024 offered a Neutral rating with a price target of $12.50. Citigroup on their part issued Neutral rating on June 25, 2024.
